NutraVeri
Ingredient database

Longevity & Cognition

Omega-3 (EPA/DHA)

Omega-3 refers to a family of long-chain fatty acids, most commonly EPA and DHA sourced from marine oils such as fish, krill, or algae. In supplements it is supplied as triglyceride, ethyl ester, or phospholipid forms standardized to specific EPA and DHA amounts.

Popularity: Very HighEvidence: Well studiedClaim risk: Caution
Readiness intelligence

Common product types

Softgels, Liquids.

Common wellness context

Founders formulate omega-3 toward everyday wellness goals such as heart-healthy lifestyle routines, cognitive and focus support positioning, joint comfort and active-recovery themes, and skin and hydration messaging. It anchors longevity and cognition stacks, prenatal and women's wellness lines, sports and recovery products, and general daily-wellness softgels. Algae-derived EPA and DHA also serve vegan and plant-forward product positioning.

Evidence posture

Omega-3 fatty acids are among the more extensively studied dietary ingredients across many wellness contexts, though outcomes vary by dose, EPA-to-DHA ratio, source form, and the population studied. Evidence is more consistent in some areas than others, and a founder should treat the literature as broad but not uniform, and as supporting general-wellness framing rather than specific outcome promises.

Claim-risk posture

Risk rises fast because omega-3 sits near several regulated disease areas. Keep language to general-wellness structure-function framing such as supporting a heart-healthy lifestyle or supporting normal cognitive wellness, and avoid any wording that points at cardiovascular disease, cholesterol numbers, mood disorders, or inflammation as a condition. Comparative or "clinically proven" phrasing invites scrutiny and should be avoided unless rigorously supportable.

Label considerations

Declare the source (fish, krill, or algal) and the chemical form (triglyceride, re-esterified triglyceride, ethyl ester, or phospholipid), and state total omega-3 alongside specific EPA and DHA milligram amounts rather than total fish oil weight, since these differ. Include allergen disclosure for fish and shellfish-derived oils. Note any standardization, oxidation freshness specs such as TOTOX or peroxide value, and carrier or antioxidant excipients like mixed tocopherols.

Dose discussion

Omega-3 products span a wide range of combined EPA and DHA per serving depending on positioning, from modest daily-wellness amounts to higher-concentration formats. Exact per-serving EPA and DHA targets, form selection, and serving size should be set with your formulator and supplier certificates of analysis, and the label should reflect actual delivered active amounts rather than crude oil weight. Do not present any amount as a treatment dose.

Safety notes

Generally well tolerated, with mild digestive effects or fishy aftertaste reported by some users. Because omega-3 may be discussed in the literature in relation to blood-thinning medications and bleeding, and is relevant to pregnancy and nursing positioning, the label should advise consumers to consult a qualified healthcare professional before use, especially if pregnant, nursing, taking medication, or planning a procedure. Do not provide diagnostic or treatment guidance.

FDA and FTC posture

Omega-3 is a dietary ingredient and is not FDA-approved; the FDA does not evaluate structure-function claims for supplements, and a disclaimer is required. The FTC expects all marketing claims to be truthful, non-misleading, and backed by competent and reliable supporting evidence.

Formula fit

Omega-3 works as a softgel or liquid centerpiece in longevity, cognition, prenatal, and recovery formulas, and pairs conceptually with vitamin D3 and other daily-foundation actives. Readiness depends on choosing the right source and form for the target audience, verifying EPA and DHA delivery against supplier certificates of analysis, controlling oxidation with freshness specs and antioxidants, and confirming allergen and labeling accuracy.

What founders usually get wrong

  • Implying it treats or prevents heart disease, lowers cholesterol, or reduces inflammation as a medical condition instead of using general-wellness framing
  • Listing total fish oil weight on the label and letting buyers assume that equals EPA and DHA content, when the active amounts are much lower
  • Ignoring source form and oxidation specs, so a cheaper ethyl ester or rancid oil undermines both quality and any wellness positioning

Caution flags

  • Discussed in literature alongside anticoagulant and antiplatelet medications
  • Oxidation and rancidity vary by source and handling; freshness specs matter
  • Source and form change actual EPA/DHA delivery vs. crude oil weight
  • Fish and shellfish allergen disclosure required for marine sources
From research to a real concept

A supplement is more than one ingredient.

Omega-3 (EPA/DHA) is a starting point. NutraVeri turns ingredients, dose logic, claims, label readiness, and manufacturing readiness into one formula-level score, free.

Free. No card. Your formula stays yours.

Related ingredients
Forward this

Useful for a client, a co-packer, or a founder friend? Send the page. Public information only.

Not ready to build yet?

See how this ingredient affects your formula score.

Get the founder readiness checklist by email, then score a formula free when you are ready. No card, no spam.

Ready now? Start a free formula score.

This page is educational readiness information, not medical, legal, or regulatory advice. Dietary supplements are not FDA-approved. NutraVeri does not diagnose, treat, or prevent any condition. Consult a qualified professional before making formulation, label, claim, or health decisions. Your formula stays yours.